The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Pharma & Human Health

AI-Powered Precision Nutrition Plan by Enbiosis Improves IBS symptoms compared to low FODMAP diet
Gastrointestinal

AI-Powered Precision Nutrition Plan by Enbiosis Improves IBS symptoms compared to low FODMAP diet

MAY 29, 2024
The Clinical Journey of a Novel LBP for Bacterial Vaginosis Developed by MGH& Biose Industrie.
Editor's Choice

The Clinical Journey of a Novel LBP for Bacterial Vaginosis Developed by MGH& Biose Industrie.

MAY 22, 2024
Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 Study for the Prevention of Recurrent C. diff Infection
Clinical & Manufacturing

Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 Study for the Prevention of Recurrent C. diff Infection

MAY 22, 2024
POSTECH and ImmunoBiome team make strides in microbiome-based cancer therapies
Oncology

POSTECH and ImmunoBiome team make strides in microbiome-based cancer therapies

MAY 20, 2024
New tool to boost battle against childhood undernutrition
Pharma & Human Health

New tool to boost battle against childhood undernutrition

MAY 17, 2024
Novo Nordisk Foundation, Wellcome, and the Gates Foundation Join Forces to Accelerate Global Health Equity and Impact
Finance

Novo Nordisk Foundation, Wellcome, and the Gates Foundation Join Forces to Accelerate Global Health Equity and Impact

MAY 8, 2024
Lallemand Health Solutions and dsm-firmenich: New Partnership for Early-Life Synbiotic Solutions
Biotics and Supplements

Lallemand Health Solutions and dsm-firmenich: New Partnership for Early-Life Synbiotic Solutions

APR 24, 2024
Millions of gamers advance biomedical research
Pharma & Human Health

Millions of gamers advance biomedical research

APR 23, 2024
SNIPR Biome receives funding from CARB-X for advancement of SNIPR001 into clinical trials in haematological cancer patients
Clinical & Manufacturing

SNIPR Biome receives funding from CARB-X for advancement of SNIPR001 into clinical trials in haematological cancer patients

APR 22, 2024
MRM Health Reports Safety and Positive Efficacy Data in Pouchitis in Phase 2a Clinical Study with MH002
Clinical & Manufacturing

MRM Health Reports Safety and Positive Efficacy Data in Pouchitis in Phase 2a Clinical Study with MH002

APR 16, 2024
AI powered “digital twin” models the infant microbiome
Pharma & Human Health

AI powered “digital twin” models the infant microbiome

APR 15, 2024